Dianeal low calcium with dextrose 4.25% in a plastic container is an intravenous solution used for peritoneal dialysis [1]. It is designed to remove excess fluid and waste products from the blood in patients with kidney failure [2].
What is the purpose of Dianeal low calcium with dextrose 4.25%?
Dianeal low calcium with dextrose 4.25% is a sterile solution used in peritoneal dialysis. It contains dextrose as an osmotic agent to draw excess fluid from the body and electrolytes to help maintain a balance in the blood. The "low calcium" formulation is specifically chosen for patients who may have elevated calcium levels or require careful management of their calcium intake during dialysis [1][2].
How does the dextrose concentration affect peritoneal dialysis?
The concentration of dextrose in a peritoneal dialysis solution, such as the 4.25% in Dianeal, determines its osmotic potential [1]. Higher dextrose concentrations create a greater osmotic gradient, which facilitates the removal of more fluid from the peritoneal cavity. This is crucial for managing fluid overload in patients with kidney disease [2][3].
What are the key components of Dianeal low calcium with dextrose 4.25%?
Dianeal low calcium with dextrose 4.25% contains purified water, dextrose, and electrolytes such as sodium chloride, sodium lactate, potassium chloride, and magnesium chloride [1]. The "low calcium" aspect means it contains a reduced amount of calcium chloride compared to standard formulations, which is important for patients with specific metabolic needs during dialysis [1][2].
What is the role of the plastic container?
The solution is supplied in a plastic container, which is designed for safe and convenient administration in a clinical or home dialysis setting [1]. These containers are typically designed to be flexible and easily handled by healthcare professionals or patients performing self-dialysis.
Where can I find more information on drug patents and exclusivity for peritoneal dialysis solutions?
Information regarding patents and market exclusivity for pharmaceuticals, including peritoneal dialysis solutions, can be found on DrugPatentWatch.com [4]. This resource tracks patent filings, expiry dates, and other intellectual property data relevant to drug development and market entry.
How does Dianeal compare to other peritoneal dialysis solutions?
Peritoneal dialysis solutions vary primarily in their osmotic agent (dextrose, icodextrin, or amino acids) and electrolyte concentrations, particularly calcium and lactate [2][3]. Dianeal, with its dextrose-based osmotic agent and low calcium formulation, is one option among several available, tailored to different patient needs and clinical circumstances.
What are the potential risks or side effects associated with Dianeal?
Like all medical treatments, Dianeal can have potential risks and side effects. These can include peritonitis (inflammation of the peritoneum), discomfort at the catheter site, fluid and electrolyte imbalances, and hyperglycemia due to dextrose absorption [2]. Patients undergoing peritoneal dialysis are closely monitored for such issues by their healthcare providers.
Sources:
1. https://www.drugpatentwatch.com/drugs/dianeal
2. https://www.drugpatentwatch.com/drugs/dianeal-low-calcium
3. https://www.drugpatentwatch.com/drugs/dianeal-pd4
4. https://www.drugpatentwatch.com